Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

BCL-2 stimulates Apoptin-induced apoptosis.

A A Danen-Van Oorschot1, A J van der Eb, M H Noteborn

  • 1Department of Molecular Cell Biology, Leiden University Medical Center, The Netherlands.

Advances in Experimental Medicine and Biology
|September 29, 1999
PubMed
Summary

Apoptin, an avian virus protein, selectively triggers cancer cell death (apoptosis) independently of p53 and is enhanced by Bcl-2. It shows promise as a safe and effective anti-tumor therapy agent.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

MN1 overexpression is driven by loss of DNMT3B methylation activity in inv(16) pediatric AML.

Oncogene·2017
Same author

miR-9 is a tumor suppressor in pediatric AML with t(8;21).

Leukemia·2013
Same author

Low frequency of DNMT3A mutations in pediatric AML, and the identification of the OCI-AML3 cell line as an in vitro model.

Leukemia·2011
Same author

Frequency and prognostic implications of JAK 1-3 aberrations in Down syndrome acute lymphoblastic and myeloid leukemia.

Leukemia·2011
Same author

Apoptin-induced apoptosis: potential for antitumor therapy.

Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy·2006
Same author

Apoptin-induced apoptosis: a review.

Apoptosis : an international journal on programmed cell death·2003

Area of Science:

  • Oncology
  • Molecular Biology
  • Virology

Background:

  • Apoptin, derived from an avian virus, induces apoptosis in tumor cells.
  • The proto-oncogene Bcl-2 typically inhibits apoptosis but unexpectedly accelerates Apoptin-induced cell death in tumor cells.
  • Apoptin's mechanism differs from p53-dependent apoptosis pathways.

Purpose of the Study:

  • To investigate Apoptin's mechanism of action in inducing apoptosis in tumor cells.
  • To explore the role of Bcl-2 in Apoptin-mediated apoptosis.
  • To evaluate Apoptin's therapeutic potential as an anti-tumor agent.

Main Methods:

  • Culturing various human tumorigenic and non-transformed cell lines.
  • Utilizing Apoptin and overexpressing Bcl-2 in cell models.

Related Experiment Videos

  • Conducting cellular localization studies (cytoplasmic vs. nuclear).
  • Assessing anti-tumor efficacy in animal models.

    • Main Results:

    • Apoptin induced p53-independent apoptosis in tumor cells (leukemia, lymphoma, EBV-transformed B cells).
    • Bcl-2 overexpression accelerated Apoptin-induced apoptosis in tumor cells, but not in normal cells.
    • Apoptin localized to the nucleus in tumor cells and the cytoplasm in normal cells.
    • Apoptin demonstrated safety and efficiency as an anti-tumor agent in animal models.

    Conclusions:

    • Apoptin selectively targets tumor cells for apoptosis, independent of p53.
    • Bcl-2 specifically enhances Apoptin's pro-apoptotic function in tumor cells.
    • Apoptin's tumor-specific activity and safety profile suggest its potential as a novel anti-cancer therapeutic.